TargetMol

Acetylsulfamerazine

Product Code:
 
TAR-T72042
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T72042-5mg5mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T72042-10mg10mg£118.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T72042-25mg25mg£146.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T72042-50mg50mg£181.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T72042-100mg100mg£218.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Acetylsulfamerazine is a secondary metabolite of sulphamethazine, which has a slight inhibitory effect on cellulose digestion and rumen endocrine activity, and has anti-microbial activity.
CAS:
127-73-1
Formula:
C13H14N4O3S
Molecular Weight:
306.34
Purity:
0.9961
SMILES:
O=C(NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC(=N2)C)C

References

Vree TB, et al. Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in 'fast' and 'slow' acetylators. Biopharm Drug Dispos. 1983;4(3):271-291. Vree TB, et al. Isolation and identification of 4-hydroxysulfamerazine and preliminary studies on its pharmacokinetics in dogs. Pharm Weekbl Sci. 1984;6(2):80-87.